📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Glutamatergic function in a genetic high-risk group for psychosis: A proton magnetic resonance spectroscopy study in individuals with 22q11.2 deletion. (2019)

First Author: Rogdaki M

Attributed to: MRC Centre for Neurodevelopmental Disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.euroneuro.2019.09.005

PubMed Identifier: 31648854

Publication URI: http://europepmc.org/abstract/MED/31648854

Type: Journal Article/Review

Volume: 29

Parent Publication: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Issue: 12

ISSN: 0924-977X